Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FD.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FU.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.4.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GY.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.3.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.4.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GY.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.57SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.35SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FU.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.3.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.3.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.10.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.9.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.76SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.43SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EU.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.4.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.59SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.24.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.17.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.63SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.2.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used